-
JAMA Cardiology
Original Investigation
February 21, 2024
Michael T.听Lu,听MD, MPH; Heather听Ribaudo,听PhD; Borek听Foldyna,听MD; Markella V.听Zanni,听MD; Thomas听Mayrhofer,听PhD; Julia听Karady,听MD, PhD; Jana听Taron,听MD; Kathleen V.听Fitch,听MSN; Sara听McCallum,听MPH; Tricia H.听Burdo,听PhD; Kayla听Paradis,听MBA; Sandeep S.听Hedgire,听MD; Nandini M.听Meyersohn,听MD; Christopher听DeFilippi,听MD; Carlos D.听Malvestutto,听MD, MPH; Audra听Sturniolo,听MS; Marissa听Diggs,听BA; Sue听Siminski,听MBA; Gerald S.听Bloomfield,听MD; Beverly听Alston-Smith,听MD; Patrice听Desvigne-Nickens,听MD; Edgar T.听Overton,听MD; Judith S.听Currier,听MD; Judith A.听Aberg,听MD; Carl J.听Fichtenbaum,听MD; Udo听Hoffmann,听MD, MPH; Pamela S.听Douglas,听MD; Steven K.听Grinspoon,听MD; REPRIEVE Trial Writing Group
open access
has multimedia
JAMA Cardiol. 2024; 9(4):323-334. 10.1001/jamacardio.2023.5661
This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.
-
JAMA
Original Investigation
May 13, 2024
Johannes Tobias听Neumann,听MD, PhD; Raphael听Twerenbold,听MD; Jessica听Weimann,听MSc; Christie M.听Ballantyne,听MD; Emelia J.听Benjamin,听MD, ScM; Simona听Costanzo,听PhD; James A.听de Lemos,听MD; Christopher R.听deFilippi,听MD; Augusto听Di Castelnuovo,听PhD; Chiara听Donfrancesco,听PhD; Marcus听D枚rr,听MD; Kai M.听Eggers,听MD; Gunnar听Engstr枚m,听MD, PhD; Stephan B.听Felix,听MD; Marco M.听Ferrario,听MD, PhD; Ron T.听Gansevoort,听MD; Simona听Giampaoli,听MD; Vilmantas听Giedraitis,听PhD; P盲r听Hedberg,听MD, PhD; Licia听Iacoviello,听MD, PhD; Torben听J酶rgensen,听MD; Frank听Kee,听MD; Wolfgang听Koenig,听MD; Kari听Kuulasmaa,听PhD; Joshua R.听Lewis,听PhD; Thiess听Lorenz,听MA; Magnus N.听Lyngbakken,听MD, PhD; Christina听Magnussen,听MD; Olle听Melander,听PhD; Matthias听Nauck,听MD; Teemu J.听Niiranen,听MD; Peter M.听Nilsson,听MD; Michael H.听Olsen,听MD; Torbjorn听Omland,听MD, PhD; Viktor听Oskarsson,听MD, PhD; Luigi听Palmieri,听PhD; Anette听Peters,听PhD; Richard L.听Prince,听MD; Vazhma听Qaderi,听MD; Ramachandran S.听Vasan,听MD; Veikko听Salomaa,听MD; Susana听Sans,听MD; J. Gustav听Smith,听MD; Stefan听S枚derberg,听MD, PhD; Barbara听Thorand,听PhD; Andrew M.听Tonkin,听MD; Hugh听Tunstall-Pedoe,听MD; Giovanni听Veronesi,听PhD; Tetsu听Watanabe,听MD; Masafumi听Watanabe,听MD; Andreas M.听Zeiher,听MD; Tanja听Zeller,听PhD; Stefan听Blankenberg,听MD; Francisco听Ojeda,听PhD
is active quiz
online first
JAMA. 2024; 10.1001/jama.2024.5596
This study evaluates the prognostic value of routinely available cardiovascular biomarkers when added to established risk factors in the identification of individuals at high risk for atherosclerotic cardiovascular disease.
-
JAMA Cardiology
Brief Report
December 13, 2023
Suman听Srinivasa,听MD; Shady听Abohashem,听MD; Allie R.听Walpert,听MSN; Carolyn N.听Dunderdale,听BA; Sanjna听Iyengar,听BS; Grace听Shen,听BS; Michael听Jerosch-Herold,听PhD; Christopher R.听deFilippi,听MD; Gregory K.听Robbins,听MD; Hang听Lee,听PhD; Raymond Y.听Kwong,听MD; Gail K.听Adler,听MD, PhD; Ahmed听Tawakol,听MD; Steven K.听Grinspoon,听MD
JAMA Cardiol. 2023; 9(2):189-194. 10.1001/jamacardio.2023.4578
This randomized clinical trial investigates if treatment with a mineralocorticoid receptor antagonist reduces arterial inflammation on 18F-fludeoxyglucose鈥損ositron emission tomography/computed tomography among persons with HIV.
-
榴莲视频 Network Open
Original Investigation
Infectious Diseases
February 8, 2021
Elizabeth T.听Rogawski McQuade,听PhD; Kristin A.听Guertin,听MPH, PhD; Lea听Becker,听MT; Darwin听Operario,听PhD; Jean听Gratz,听BSc; Dave听Guan,听MEng; Fauzia听Khan,听MMCi; Jennifer听White,听BSN; Timothy L.听McMurry,听PhD; Bhruga听Shah,听MS; Stephanie听Garofalo,听MSN; Matt听Southerland,听BS; Kelly听Bear,听BS; John听Brush,听MD; Cynthia听Allen,听BS; Amy听Frayser,听BS; Rebecca听Vokes,听MHA; Rashmi听Pershad,听MPhil; Lilian听Peake,听MD, MPH; Christopher听deFilippi,听MD; Kathleen听Barackman,听MSN; Gonzalo听Bearman,听MD, MPH; Andrea听Bidanset,听MHA; Francis听Farrell,听PhD; David听Trump,听MD, MPH; Eric R.听Houpt,听MD
open access
榴莲视频 Netw Open. 2021; 4(2):e2035234. 10.1001/jamanetworkopen.2020.35234
This cross-sectional study assesses the statewide prevalence of previous infection with severe acute respiratory syndrome coronavirus 2 and the risk factors associated with infection among adult outpatients in Virginia.
-
JAMA Cardiology
Original Investigation
January 1, 2019
Ambarish听Pandey,听MD, MSCS; Neil听Keshvani,听MD; Colby听Ayers,听MS; Adolfo听Correa,听MD; Mark H.听Drazner,听MD; Alana听Lewis,听MD; Carlos J.听Rodriguez,听MD; Michael E.听Hall,听MD; Ervin R.听Fox,听MD; Robert J.听Mentz,听MD; Christopher听deFilippi,听MD; Stephen L.听Seliger,听MD, MS; Christie M.听Ballantyne,听MD; Ian J.听Neeland,听MD; James A.听de Lemos,听MD; Jarett D.听Berry,听MD, MS
free access
JAMA Cardiol. 2019; 4(1):51-58. 10.1001/jamacardio.2018.4300
This longitudinal cohort study explores the association of left ventricular hypertrophy and high-sensitivity cardiac troponin I levels and the risk of heart failure among African Americans enrolled in the Jackson Heart Study.
-
JAMA Cardiology
Original Investigation
March 1, 2018
Rudolf A.听de Boer,听MD, PhD; Matthew听Nayor,听MD, MPH; Christopher R.听deFilippi,听MD; Danielle听Enserro,听PhD; Vijeta听Bhambhani,听MS, MPH; Jorge R.听Kizer,听MD, MSc; Michael J.听Blaha,听MD, MPH; Frank P.听Brouwers,听MD, PhD; Mary听Cushman,听MD; Joao A. C.听Lima,听MD; Hossein听Bahrami,听MD, PhD, MPH; Pim听van der Harst,听MD, PhD; Thomas J.听Wang,听MD; Ron T.听Gansevoort,听MD, PhD; Caroline S.听Fox,听MD, MPH; Hanna K听Gaggin,听MD, MPH; Willem J.听Kop,听PhD; Kiang听Liu,听PhD; Ramachandran S.听Vasan,听MD; Bruce M.听Psaty,听MD, PhD; Douglas S.听Lee,听MD, PhD; Hans L.听Hillege,听MD, PhD; Traci M.听Bartz,听MS; Emelia J.听Benjamin,听MD, ScM; Cheeling听Chan,听MS; Matthew听Allison,听MD, MPH; Julius M.听Gardin,听MD, MBA; James L.听Januzzi听Jr,听MD; Sanjiv J.听Shah,听MD; Daniel听Levy,听MD; David M.听Herrington,听MD; Martin G.听Larson,听ScD; Wiek H.听van Gilst,听PhD; John S.听Gottdiener,听MD; Alain G.听Bertoni,听MD, MPH; Jennifer E.听Ho,听MD
free access
JAMA Cardiol. 2018; 3(3):215-224. 10.1001/jamacardio.2017.4987
This longitudinal multicohort study evaluates the associations of 12 cardiovascular biomarkers with the development of heart failure with preserved ejection fraction vs heart failure with reduced ejection fraction.
-
JAMA
Original Contribution
July 16, 2003
Christopher deFilippi, MD; Steven Wasserman, PhD; Salvatore Rosanio, MD, PhD; Eric Tiblier, MD; Heidi Sperger, BS; Monica Tocchi, MD; Robert Christenson, PhD; Barry Uretsky, MD; Mathew Smiley, MD; Judith Gold, MD; Henry Muniz, MD; John Badalamenti, MD; Charles Herzog, MD; William Henrich, MD
free access
JAMA. 2003; 290(3):353-359. 10.1001/jama.290.3.353
-
JAMA Internal Medicine
Original Investigation
Less Is More
May 13, 2013
Alexis L. Beatty, MD; Ivy A. Ku, MD, MAS; Robert H. Christenson, PhD; Christopher R. DeFilippi, MD; Nelson B. Schiller, MD; Mary A. Whooley, MD
free access
JAMA Intern Med. 2013; 173(9):763-769. 10.1001/jamainternmed.2013.116
Beatty et al determine the association of high-sensitivity cardiac troponin T levels with structural and functional measures of heart disease and secondary cardiovascular events. See editor鈥檚 note by O鈥橫alley.
-
JAMA
Letters
March 23, 2011
James A. de Lemos, MD; Robert H. Christenson, PhD; Christopher R. deFilippi, MD
JAMA. 2011; 305(12):1196-1197. 10.1001/jama.2011.346
-
JAMA
Original Contribution
December 8, 2010
Christopher R. deFilippi, MD; James A. de Lemos, MD; Robert H. Christenson, PhD; John S. Gottdiener, MD; Willem J. Kop, PhD; Min Zhan, PhD; Stephen L. Seliger, MD, MS
free access
JAMA. 2010; 304(22):2494-2502. 10.1001/jama.2010.1708
-
JAMA
Original Contribution
July 14, 1999
Salvatore Rosanio, MD, PhD; Monica Tocchi, MD; David Cutler, MD; Barry F. Uretsky, MD; George A. Stouffer, MD; Christopher R. deFilippi, MD; Edward J. MacInerney, MD; Susan R. Runge, MD; Joann Aaron, MA; Javier Otero, MD; Sandeep Garg, MD; Marschall S. Runge, MD, PhD
free access
JAMA. 1999; 282(2):145-152. 10.1001/jama.282.2.145